Literature DB >> 21497418

[Osteonecrosis of the jaws secondary to oral bisphosphonates: a presentation of 3 cases].

Francisco Cardona Tortajada, Esther Sainz Gómez, Fernando Giner Muñoz, Jorge Figuerido Garmendia.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21497418      PMCID： PMC7025242          DOI： 10.1016/j.aprim.2010.12.013

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  4 in total

1.  [Maxillary osteonecrosis associated with the use of zoledronate: Presentation of three cases].

Authors:  Elisenda Bolívar Puigoriol; Núria Camprodon Tuneu; Cristina Farriols Danés; José Planas Domingo
Journal:  Aten Primaria       Date:  2010-02-02       Impact factor: 1.137

Review 2.  Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not just a sporadic coincidence--a multi-centre study.

Authors:  Sven Otto; Mario Hakim Abu-Id; Stefano Fedele; Patrick H Warnke; Stephan T Becker; Andreas Kolk; Thomas Mücke; Gerson Mast; Robert Köhnke; Elias Volkmer; Florian Haasters; Olivier Lieger; Tateyuki Iizuka; Stephen Porter; Giuseppina Campisi; Giuseppe Colella; Oliver Ploder; Andreas Neff; Jörg Wiltfang; Michael Ehrenfeld; Thomas Kreusch; Klaus-Dietrich Wolff; Stephen R Stürzenbaum; Matthias Schieker; Christoph Pautke
Journal:  J Craniomaxillofac Surg       Date:  2010-07-02       Impact factor: 2.078

Review 3.  [Bisphosphonate-related osteonecrosis of the jaws. An update].

Authors:  F Cardona; J V Bagán; E Sáinz; J Figuerido; F Giner; F J Vidán
Journal:  An Sist Sanit Navar       Date:  2009 Sep-Dec       Impact factor: 0.829

4.  Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases.

Authors:  Salvatore L Ruggiero; Bhoomi Mehrotra; Tracey J Rosenberg; Stephen L Engroff
Journal:  J Oral Maxillofac Surg       Date:  2004-05       Impact factor: 1.895
  4 in total
  1 in total

1.  [Oral bisphosphonates, denosumab and osteonecrosis of the jaws].

Authors:  Francisco Cardona Tortajada; Esther Sainz Gómez; David Viñal Lozano
Journal:  Aten Primaria       Date:  2014-12-15       Impact factor: 1.137
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.